Cancer-free for nearly 20 years, RIT graduate student Bryona Hamilton seeks to educate patients, survivors, and family ...

HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a late-stage pharmaceutical company currently trading near its 52-week low of $0.66, announced it has received the first European regulatory approval ...

Approximately one in three patients diagnosed with cancer in Ontario presented to an ED in the 90 days preceding their diagnosis, according to findings published in Canadian Medical Association ...

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon emission ...